![](/img/cover-not-exists.png)
Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein
Jay S. Dela Cruz, Sherie L. Morrison, Manuel L. PenichetVolume:
23
Year:
2005
Language:
english
DOI:
10.1016/j.vaccine.2005.04.041
File:
PDF, 458 KB
english, 2005